Japanese Aerospace & Defense Stock News

TSE:6324
TSE:6324Machinery

Harmonic Drive Systems (TSE:6324) Valuation Check As New 2026 To 2030 Plan Takes Shape

Harmonic Drive Systems (TSE:6324) has scheduled a May 13, 2026 board meeting to review its current 2024–2026 medium term management plan and craft a new roadmap covering fiscal years 2026 to 2030. See our latest analysis for Harmonic Drive Systems. The board meeting lands at a time when momentum in the stock has been strong, with a 30 day share price return of 45.66% and a year to date share price return of 70.31%. The 1 year total shareholder return of 91.57% contrasts with more modest 3 and...
TSE:8001
TSE:8001Trade Distributors

How Investors Are Reacting To ITOCHU (TSE:8001) Expanding Its Supply Role With Nissin Foods

Nissin Foods Company Limited previously announced that on May 7, 2026, it entered into a Master Raw Materials and Products Procurement Agreement with ITOCHU Corporation, running from January 1, 2026 to December 31, 2028 and setting arm’s length, market‑benchmarked pricing for a wide range of food raw materials and merchandises. The agreement outlines a jump in expected annual procurement caps from about HK$12.70 million–HK$22.80 million historically to as much as HK$92.30 million by 2028,...
TSE:7267
TSE:7267Auto

Is Honda Motor (TSE:7267) Pricing Look Stretched After Recent Share Price Rebound?

Investors may be wondering whether Honda Motor stock is fairly valued at ¥1,386, or if the current price leaves too much potential value on the table for long term investors. The stock has recently gained 5.0% over the last week and 3.3% over the last month, while the year to date return is down 11.0% and the 1 year return is 2.8%. Recent coverage of Honda Motor has focused on its position in the global auto sector and how investors are weighing long term demand trends against shorter term...
TSE:8725
TSE:8725Insurance

MS&AD Insurance Group Holdings (TSE:8725) Earnings Decline Forecast Challenges Bullish Valuation Narrative

MS&AD Insurance Group Holdings (TSE:8725) has wrapped up FY 2026 with fourth quarter revenue of ¥1.6 trillion and basic EPS of ¥88.95, while trailing twelve month revenue sits at ¥7.3 trillion and basic EPS at ¥528.87, set against a current share price of ¥4,387. Over recent periods the company has seen quarterly revenue range from ¥1.3 trillion in FY 2025 Q4 to ¥2.1 trillion in FY 2026 Q2, with basic EPS moving between ¥43.26 and ¥179.71, and TTM net income holding in the ¥691.66 billion to...
TSE:4523
TSE:4523Pharmaceuticals

Is Eisai (TSE:4523) Offering An Opportunity After Recent Share Price Pullback?

Wondering whether Eisai's current share price reflects its true worth, or if the market is mispricing the stock. After a mixed stretch where the stock is up 10.4% over the past year but down 10.0% over the last week, 13.5% over the last month and 11.3% year to date, many investors are reassessing what a fair price might look like. Recent coverage has focused on Eisai's position in the pharmaceuticals sector and how sentiment around its pipeline and partnerships could be influencing these...
TSE:7751
TSE:7751Tech

Is It Time To Reassess Canon (TSE:7751) After Recent Share Price Weakness?

If you are wondering whether Canon's share price still offers value or if most of the opportunity is already priced in, it helps to start with how the stock has actually behaved and what the current valuation signals are telling you. Canon's stock recently closed at ¥4,184, with the price edging up about 0.4% over the last week, while also falling around 6.8% over the past month and declining roughly 11.5% year to date. Over a longer horizon, Canon has returned about 35.7% over three years...
TSE:5831
TSE:5831Banks

The Bull Case For Shizuoka Financial Group (TSE:5831) Could Change Following Earnings And Leadership Moves

Shizuoka Financial Group, Inc. recently reported full-year results for the period ended March 31, 2026, posting net interest income of ¥169,561 million, net income of ¥90,469 million, and basic earnings per share from continuing operations of ¥167.66. On the same day, the company’s board met to consider changes to its representative directors, putting both earnings quality and leadership decisions in focus for investors. We will now examine how the combination of solid reported earnings and...
TSE:4413
TSE:4413IT

Asian Stocks Estimated To Be Undervalued By Up To 40.8%

As global markets grapple with rising inflation and geopolitical uncertainties, the Asian stock market presents unique opportunities for investors seeking value. In this environment, identifying undervalued stocks can be particularly rewarding, as these equities may offer potential for growth despite broader economic challenges.
TSE:4503
TSE:4503Pharmaceuticals

A Look At Astellas Pharma (TSE:4503) Valuation As New Oncology Data Approaches ASCO 2026

Astellas Pharma (TSE:4503) is back in focus after announcing a broad slate of oncology presentations for the 2026 ASCO meeting, including long term data on enfortumab vedotin combinations and updated prostate cancer outcomes. See our latest analysis for Astellas Pharma. The recent ASCO announcement comes after a mixed year in the market, with the share price at ¥2,317, a 1-year total shareholder return of 76.57% and a 5-year total shareholder return of 67.14%. However, the 30-day share price...
TSE:7011
TSE:7011Machinery

Should Mitsubishi Heavy Industries’ Strong FY2026 Results and Dividend Plans Require Action From Mitsubishi Heavy Industries (TSE:7011) Investors?

In May 2026, Mitsubishi Heavy Industries reported full-year results showing sales of ¥4,974,168 million and net income of ¥332,129 million for the year ended March 31, 2026, alongside a board meeting to consider dividends of surplus. The sharp year-on-year increase in both sales and earnings per share suggests improved operational efficiency and stronger profit generation across the business portfolio. Against this backdrop of higher full-year net income, we will examine how the results may...